OBJECTIVE: To identify features on B-mode ultrasonography (US) prevalent in symptomatic plaques and correlate these findings with histopathologic markers of plaque instability. METHODS: Carotid endarterectomy (CEA) plaques from symptomatic and asymptomatic patients with critical stenoses (>70%) were qualitatively assessed using preoperative B-mode US for echolucency and calcific acoustic shadowing. US echolucency was quantitated ex vivo using computerized techniques for gray-scale median (GSM) analysis. Histopathologic correlates for US plaque echolucency (percentage of necrotic core area) and acoustic shadowing (percentage of calcification area) were determined. RESULTS: Fifty CEA plaques were collected from 48 patients (46 unilateral and two bilateral); 26 of these plaques were from symptomatic patients. Age, degree of stenosis, and atherosclerotic risk factors were similar for the symptomatic and asymptomatic patients. Using preoperative B-mode US, 58%, 35%, and 7% of symptomatic plaques and 18%, 41%, and 41% of asymptomatic plaques were found to be echolucent, echogenic, and calcific, respectively (P < .05). Using ex-vivo B-mode US and GSM analysis, symptomatic plaques were more echolucent (41 +/- 19) than asymptomatic plaques (60 +/- 13), P < .03. A strong inverse correlation was found between the percent plaque necrotic area core and GSM (R = -0.9, P < .001). Percentage of calcification area in plaques with acoustic shadowing was 66% and only 27% in those without acoustic shadowing (P < .05). CONCLUSIONS: Using B-mode US, symptomatic plaques are more echolucent and less calcified than asymptomatic plaques and are associated with a greater degree of histopathologic plaque necrosis. Such features are indicative of plaque instability and should be considered in the decision-making algorithm when selecting patients with high-grade asymptomatic carotid stenosis for intervention.
OBJECTIVE: To identify features on B-mode ultrasonography (US) prevalent in symptomatic plaques and correlate these findings with histopathologic markers of plaque instability. METHODS: Carotid endarterectomy (CEA) plaques from symptomatic and asymptomatic patients with critical stenoses (>70%) were qualitatively assessed using preoperative B-mode US for echolucency and calcific acoustic shadowing. US echolucency was quantitated ex vivo using computerized techniques for gray-scale median (GSM) analysis. Histopathologic correlates for US plaque echolucency (percentage of necrotic core area) and acoustic shadowing (percentage of calcification area) were determined. RESULTS: Fifty CEA plaques were collected from 48 patients (46 unilateral and two bilateral); 26 of these plaques were from symptomatic patients. Age, degree of stenosis, and atherosclerotic risk factors were similar for the symptomatic and asymptomatic patients. Using preoperative B-mode US, 58%, 35%, and 7% of symptomatic plaques and 18%, 41%, and 41% of asymptomatic plaques were found to be echolucent, echogenic, and calcific, respectively (P < .05). Using ex-vivo B-mode US and GSM analysis, symptomatic plaques were more echolucent (41 +/- 19) than asymptomatic plaques (60 +/- 13), P < .03. A strong inverse correlation was found between the percent plaque necrotic area core and GSM (R = -0.9, P < .001). Percentage of calcification area in plaques with acoustic shadowing was 66% and only 27% in those without acoustic shadowing (P < .05). CONCLUSIONS: Using B-mode US, symptomatic plaques are more echolucent and less calcified than asymptomatic plaques and are associated with a greater degree of histopathologic plaque necrosis. Such features are indicative of plaque instability and should be considered in the decision-making algorithm when selecting patients with high-grade asymptomatic carotid stenosis for intervention.
Authors: Cheuk F Chan; Niall G Keenan; Sonia Nielles-Vallespin; Peter Gatehouse; Mary N Sheppard; Joseph J Boyle; Dudley J Pennell; David N Firmin Journal: J Cardiovasc Magn Reson Date: 2010-03-26 Impact factor: 5.364
Authors: Stephen J Murphy; Soon T Lim; Justin A Kinsella; Sean Tierney; Bridget Egan; Tim M Feeley; Clare Dooley; James Kelly; Sinead M Murphy; Richard A Walsh; Ronan Collins; Tara Coughlan; Desmond O'Neill; Joseph A Harbison; Prakash Madhavan; Sean M O'Neill; Mary P Colgan; Jim F Meaney; George Hamilton; Dominick Jh McCabe Journal: J Cereb Blood Flow Metab Date: 2019-11-11 Impact factor: 6.200
Authors: Alyssa A Appel; Cheng-Ying Chou; Howard P Greisler; Jeffery C Larson; Sunil Vasireddi; Zhong Zhong; Mark A Anastasio; Eric M Brey Journal: Am J Surg Date: 2012-11 Impact factor: 2.565
Authors: F Molinari; K M Meiburger; G Zeng; L Saba; U Rajendra Acharya; L Famiglietti; N Georgiou; A Nicolaides; R Sriswan Mamidi; H Kuper; J S Suri Journal: Int Angiol Date: 2012-02 Impact factor: 2.789
Authors: Carol C Mitchell; James H Stein; Thomas D Cook; Shahriar Salamat; Xiao Wang; Tomy Varghese; Daren C Jackson; Carolina Sandoval Garcia; Stephanie M Wilbrand; Robert J Dempsey Journal: Ultrasound Med Biol Date: 2016-10-05 Impact factor: 2.998
Authors: Dixon Yang; Sunil Iyer; Hannah Gardener; David Della-Morte; Milita Crisby; Chuanhui Dong; Ken Cheung; Consuelo Mora-McLaughlin; Clinton B Wright; Mitchell S Elkind; Ralph L Sacco; Tatjana Rundek Journal: Cerebrovasc Dis Date: 2015-07-25 Impact factor: 2.762
Authors: John J Ricotta; Jose Pagan; Michalis Xenos; Yared Alemu; Shmuel Einav; Danny Bluestein Journal: Med Biol Eng Comput Date: 2008-11-11 Impact factor: 2.602